Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,333,151
+$521,317 QoQ
Shares Held
7,910
+38.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#362
of 768 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026INCEPTIONR LLC holds $4,209,930 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (31.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,910 | $1,333,151 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
14,757 | $686,348 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
4,868 | $540,055 | |
| 4 | PRGO |
PERRIGO Co plc
|
51,202 | $531,988 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
5,693 | $471,266 | |
| 6 | LQDA |
Liquidia Corp
|
4,871 | $388,364 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
14,624 | $146,240 | |
| 8 | EOLS |
Evolus, Inc.
|
16,213 | $112,518 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,333,151 | 7,910 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $811,834 | 5,724 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $240,067 | 1,910 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $818,310 | 5,944 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||